Sign Up to like & get
recommendations!
1
Published in 2022 at "European Respiratory Journal"
DOI: 10.1183/13993003.02309-2021
Abstract: Background Our objective was to determine the comparative bronchodilator, systemic β2-agonist, cardiovascular and adverse effects of salbutamol 200 µg and budesonide/formoterol 200/6 µg when taken repeatedly in stable asthma. Methods This open-label, crossover, single-centre, controlled trial randomised…
read more here.
Keywords:
formoterol;
formoterol 200;
min;
salbutamol 200 ... See more keywords